Company intelligence / Profile preview

Centerline Biomedical

Cleveland, Ohio, United States

Ownership: Private
Employees: ~39
Development stage: Other

Overview

The flagship IOPS® platform has FDA 510(k) clearance and demonstrated its ability to provide high-precision, real-time navigation during endovascular procedures, notably reducing reliance on radiation and improving surgical accuracy. Initial clinical use began in 2020, and multiple product generations have since received FDA clearance.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Surgical Medical Devices

Partnerships

Cleveland ClinicGE HealthcareORSIF

Beyond the preview

Go deeper on Centerline Biomedical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Centerline Biomedical.

Explore the full profile